PSG Versus Oxim-capnography to Setup Home NIV

The Clinical Effectiveness of PSG Versus Limited Respiratory Polygraphy During NIV Set up in COPD-OSA Overlap Syndrome: A Randomised Controlled Trial

The study aims to compare 2 different strategies used to setup non-invasive ventilation in patients with OCPD-OSA overlap.

Study Overview

Status

Completed

Conditions

Detailed Description

With limited comparative data to support the different strategies, there is substantial variation across Europe and the United States in the methods used by clinicians to set up home non-invasive ventilation (NIV) for patients with chronic respiratory failure as a consequence of sleep disordered breathing. Indeed with few data to support the practice, many centres employ full montage polysomnography, which is not only a significant physical burden to the patient but also a financial burden to the healthcare provider in terms of the facilities required, staff training and equipment.

The investigators propose to undertake a randomised controlled trial to compare the clinical effectiveness, in terms of the change in daytime arterial partial pressure of carbon dioxide (PaCO2) at 3 months, of limited respiratory polygraphy and full polysomnography to set up NIV in patients with COPD-OSA overlap. Secondary outcome measures at 3 months will include overnight control of gas exchange, subjective sleep quality, health related quality of life and ventilator adherence. COPD-OSA overlap are a patient group that have a rising prevalence with limited data currently available detailing NIV set up, which wholly supports the rationale of using this increasingly important group as a target population for this trial.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Phase 2

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COPD (as defined by GOLD criteria[4])
  • OSA (ODI > 7.5 events/hr, AHI > 5events/hr)
  • PaCO2 > 6 kPa
  • BMI > 30 kg/m2

Exclusion Criteria:

  • Decompensated respiratory failure (pH < 7.35)
  • Inability to tolerate NIV (< 4 hours usage at in hospital titration)
  • Contraindication to NIV
  • Pregnancy
  • Aged <18
  • Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Full Polysomnography
Patients will have NIV settings established using overnight full polysomnography.
Full sleep and respiratory monitoring with EEG
Other Names:
  • Polysomnography
Active Comparator: Oximetry-capnography
Patients will have NIV settings established using only Oximetry-capnography and subjective sleep comfort.
Limited monitoring with nurse observation and continuous oximetry-capnography overnight for NIV titration.
Other Names:
  • Limited respiratory monitoring

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PaCO2 (Arterial blood gas analysis)
Time Frame: 3 months
Arterial blood gas analysis
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health related quality of life (CAT, SRI)
Time Frame: 3 months
CAT, SRI
3 months
Spirometry (FEV1, FVC)
Time Frame: 3 months
FEV1, FVC
3 months
Subjective sleep comfort (VAS)
Time Frame: 3 months
VAS
3 months
Objective sleep comfort (Actigraphy)
Time Frame: 3 months
Actigraphy
3 months
Respiratory mechanics (to include, work of breathing, PEEPdyn, Cdyn, EMGdi, EMGpara)
Time Frame: Day 1
Invasive respiratory mechanics performed on discharge NIV settings to include, work of breathing, PEEPdyn, Cdyn, EMGdi, EMGpara
Day 1
NIV compliance (machine recorded)
Time Frame: 3 months
NIV machine recorded compliance
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

November 1, 2015

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

May 12, 2015

First Submitted That Met QC Criteria

May 14, 2015

First Posted (Estimate)

May 15, 2015

Study Record Updates

Last Update Posted (Estimate)

July 12, 2016

Last Update Submitted That Met QC Criteria

July 11, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 14/LO/2088

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on OSA

Clinical Trials on Full polysomnography

Subscribe